YOUSEFI, B.; SAMADI, N.; BARADARAN, B.; RAMESHKNIA, V.; SHAFIEI-IRANNEJAD, V.; MAJIDINIA, M.; TARGHAZE, N.; ZARGHAMI, N. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Cellular and Molecular Biology, [S. l.], v. 61, n. 8, p. 118–122, 2015. Disponível em: https://mail.cellmolbiol.org/index.php/CMB/article/view/768. Acesso em: 21 nov. 2024.